Moderna said Tuesday that a new lab study shows its COVID-19 vaccine should provide protection against emerging mutations of the CCP (Chinese Communist Party) virus, including the highly contagious Delta variant that has health officials on edge. In vitro neutralization studies of blood obtained from eight people one week after they were vaccinated with their second dose of Moderna’s vaccine, mRNA-1273, show the product provoked an antibody response against all the virus variants tested, the company said in a release. “Vaccination with the Moderna COVID-19 Vaccine produced neutralizing titers against all variants tested, including additional versions of the Beta variant (B.1.351, first identified in South Africa), three lineage variants of B.1.617 (first identified in India), including the Kappa (B.1.617.1) and the Delta variants (B.1.617.2); the Eta variant (B.1.525, first identified in Nigeria); and the A.23.1 and A.VOI.V2 variants first identified in Uganda and Angola, respectively,” Moderna said. Moderna said its …